Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Hallucinogenic drugs as precipitants of schizophrenia.

Breakey WR, Goodell H, Lorenz PC, McHugh PR.

Psychol Med. 1974 Aug;4(3):255-61. No abstract available.

PMID:
4427973
2.

Drug-related schizophrenic syndromes.

Stone MH.

Int J Psychiatry. 1973 Dec;11(4):391-437. Review. No abstract available.

PMID:
4600400
3.

Molecular pharmacology of hallucinogens.

Johnston VS, Bradley RJ.

Recent Adv Biol Psychiatry. 1968;10:74-99. Review. No abstract available.

PMID:
4872761
4.

Treatment of acute hallucinogenic drug toxicity: specific pharmacological intervention.

Consroe PF.

Bull Natl Clgh Poison Control Cent. 1973 Jan-Feb:1-7. Review. No abstract available.

PMID:
4571809
5.

CHEMICAL PSYCHOSES.

HOLLISTER LE.

Annu Rev Med. 1964;15:203-14. Review. No abstract available.

PMID:
14133845
6.

Adverse reactions to psychedelic drugs. A review of the literature.

Strassman RJ.

J Nerv Ment Dis. 1984 Oct;172(10):577-95. Review.

PMID:
6384428
7.

Shazam. Or, the medical management of non-opiate drug abuse.

Glaser FB.

Pa Med. 1971 Jul;74(7):52-8. Review. No abstract available.

PMID:
4933079
8.

Drug induced psychosis.

Poole R, Brabbins C.

Br J Psychiatry. 1996 Feb;168(2):135-8. Review. No abstract available.

PMID:
8837900
9.

Clinical aspects of the various forms of nonmedical use of drugs. II.

Isbell H.

Anesth Analg. 1971 Nov-Dec;50(6):897-905. Review. No abstract available.

PMID:
4942827
10.

Adverse consequences of lysergic acid diethylamide.

Abraham HD, Aldridge AM.

Addiction. 1993 Oct;88(10):1327-34. Review.

PMID:
8251869
11.

Toward a rational approach to psychedelics: the controversy over popular use from a clinical viewpoint.

Weech AA Jr, Bibb RE.

Compr Psychiatry. 1970 Jan;11(1):57-68. Review. No abstract available.

PMID:
4903887
12.

Psychedelic drugs.

Kieffer SN, Mortiz TB.

Pa Med. 1968 Apr;71(4):57-67. Review. No abstract available.

PMID:
4870533
13.

Psychedelic drugs.

Kieffer SN, Moritz TB.

Pa Med. 1968 Apr;71(4):57-67. Review. No abstract available.

PMID:
4869313
14.

A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice.

Schneier FR, Siris SG.

J Nerv Ment Dis. 1987 Nov;175(11):641-52. Review.

PMID:
3316490
15.

Analysis of hallucinogenic drugs.

Sperling A.

J Chromatogr Sci. 1972 May;10(5):268-75. Review. No abstract available.

PMID:
4561542
16.

Catecholamines in the brain as mediators of amphetamine psychosis.

Snyder SH.

Arch Gen Psychiatry. 1972 Aug;27(2):169-79. Review. No abstract available.

PMID:
4339577
17.

Hallucinogenic drugs.

[No authors listed]

Anesth Analg. 1968 Jan-Feb;47(1):72-6. Review. No abstract available.

PMID:
4866081
18.

[Recent trends in hallucinogens].

Hirai T.

Nihon Ishikai Zasshi. 1970 Dec 15;64(12):1348-55. Review. Japanese. No abstract available.

PMID:
4924530
19.

Serotonergic hallucinogens as translational models relevant to schizophrenia.

Halberstadt AL, Geyer MA.

Int J Neuropsychopharmacol. 2013 Nov;16(10):2165-80. doi: 10.1017/S1461145713000722. Epub 2013 Aug 13. Review.

20.

Hallucinogens.

Brown RT, Braden NJ.

Pediatr Clin North Am. 1987 Apr;34(2):341-7. Review.

PMID:
3550656

Supplemental Content

Support Center